NASDAQ: CCCC
C4 Therapeutics Inc Stock Ownership - Who owns C4 Therapeutics?

Insider buying vs selling

Have C4 Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donna Roy GroganDirector2025-04-019,581$1.44
$13.75kBuy
Kenneth Carl AndersonDirector2025-04-017,841$1.44
$11.25kBuy
Scott N. BoyleChief Business Officer2025-02-18669$3.15
$2.11kSell
Andrew HirschPresident CEO2025-02-159,370$3.18
$29.80kSell
Andrew HirschPresident CEO2025-02-1412,847$3.18
$40.85kSell
Mark MosslerChief Accounting Officer2025-02-141,586$3.18
$5.04kSell
Kendra AdamsChief Financial Officer2025-02-144,559$3.18
$14.50kSell
Jolie SiegelChief Legal Officer2025-02-142,914$3.18
$9.27kSell
Scott N. BoyleChief Business Officer2025-02-14490$3.15
$1.54kSell
Scott N. BoyleChief Business Officer2025-02-142,368$3.18
$7.53kSell

1 of 4

CCCC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CCCC insiders and whales buy or sell their stock.

CCCC Shareholders

What type of owners hold C4 Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc A. Cohen11.70%8,308,874$13.13MInsider
Soleus Capital Management LP9.83%6,978,942$11.03MInstitution
Lynx1 Capital Management LP9.65%6,852,744$10.83MInstitution
Alain J. Cohen8.58%6,094,001$9.63MInsider
Wasatch Advisors LP8.55%6,072,601$9.59MInstitution
Blackrock Inc7.83%5,558,851$8.78MInstitution
Ra Capital Management LP6.87%4,878,000$7.71MInstitution
Orbimed Advisors LLC6.17%4,377,900$6.92MInstitution
Morgan Stanley5.41%3,839,469$6.07MInstitution
Vanguard Group Inc4.71%3,345,973$5.29MInstitution

1 of 3

CCCC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CCCC78.11%21.89%Net SellingNet Selling
ATOS23.17%14.77%Net BuyingNet Buying
TNXP48.86%51.14%Net SellingNet Selling
TVRD3.49%96.51%Net SellingNet Selling
LCTX41.22%58.78%Net BuyingNet Selling

C4 Therapeutics Stock Ownership FAQ

Who owns C4 Therapeutics?

C4 Therapeutics (NASDAQ: CCCC) is owned by 90.72% institutional shareholders, 25.43% C4 Therapeutics insiders, and 0.00% retail investors. Marc A. Cohen is the largest individual C4 Therapeutics shareholder, owning 8.31M shares representing 11.70% of the company. Marc A. Cohen's C4 Therapeutics shares are currently valued at $13.63M.

If you're new to stock investing, here's how to buy C4 Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.